Sean Laaman
Stock Analyst at Morgan Stanley
Total Price Targets
13
Stocks Covered
11
Sectors
Healthcare
Most Recent
Feb 2, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Sean Laaman
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| EXEL | Exelixis, Inc. | $49.00 | $43.81 | +11.8% | 2 | Feb 2, 2026 |
| ERAS | Erasca, Inc. | $10.00 | $10.13 | -1.3% | 1 | Jan 26, 2026 |
| JAZZ | Jazz Pharmaceuticals plc | $225.00 | $202.38 | +11.2% | 2 | Jan 8, 2026 |
| CGON | CG Oncology, Inc. Common stock | $89.00 | $66.29 | +34.3% | 1 | Jan 8, 2026 |
| DNLI | Denali Therapeutics Inc. | $40.00 | $18.49 | +116.3% | 1 | Jan 8, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $98.00 | $54.20 | +80.8% | 1 | Oct 28, 2025 |
| ZBIO | Zenas BioPharma, Inc. | $34.00 | $19.50 | +74.4% | 1 | Oct 27, 2025 |
| AXSM | Axsome Therapeutics, Inc. | $194.00 | $204.09 | -4.9% | 1 | Oct 20, 2025 |
| ACAD | ACADIA Pharmaceuticals Inc. | $24.00 | $21.95 | +9.3% | 1 | May 20, 2025 |
| HALO | Halozyme Therapeutics, Inc. | $62.00 | $64.04 | -3.2% | 1 | May 14, 2025 |
| RMD | ResMed Inc. | $250.00 | $205.50 | +21.7% | 1 | Aug 4, 2021 |
Recent Activity
- Feb 2, 2026— Set$49.00price target onEXEL(Exelixis, Inc.)
- Jan 26, 2026— Set$10.00price target onERAS(Erasca, Inc.)
- Jan 8, 2026— Set$40.00price target onDNLI(Denali Therapeutics Inc.)
- Jan 8, 2026— Set$225.00price target onJAZZ(Jazz Pharmaceuticals plc)
- Jan 8, 2026— Set$89.00price target onCGON(CG Oncology, Inc. Common stock)
- Nov 17, 2025— Set$205.00price target onJAZZ(Jazz Pharmaceuticals plc)
- Oct 28, 2025— Set$98.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Oct 27, 2025— Set$34.00price target onZBIO(Zenas BioPharma, Inc.)
- Oct 20, 2025— Set$194.00price target onAXSM(Axsome Therapeutics, Inc.)
- May 20, 2025— Set$24.00price target onACAD(ACADIA Pharmaceuticals Inc.)
- May 14, 2025— Set$62.00price target onHALO(Halozyme Therapeutics, Inc.)
- May 14, 2025— Set$47.00price target onEXEL(Exelixis, Inc.)
- Aug 4, 2021— Set$250.00price target onRMD(ResMed Inc.)
Frequently Asked Questions
Who is Sean Laaman?
Sean Laaman is a stock analyst at Morgan Stanley covering 11 stocks primarily in Healthcare. They have issued 13 price targets since Aug 4, 2021.
What stocks does Sean Laaman cover?
Sean Laaman currently covers 11 stocks, including EXEL, JAZZ, ERAS, CGON, DNLI.
What is Sean Laaman's latest price target?
Sean Laaman's most recent price target was $49.00 on EXEL (Exelixis, Inc.), set on Feb 2, 2026.
What is Sean Laaman's highest price target?
Sean Laaman's highest issued price target is $250.00 on RMD, set on Aug 4, 2021.
More Analysts at Morgan Stanley
Coverage based on publicly published price targets. Not investment advice.